86-21-64556180

cpd-service@caerulumpharma.com

Home
About Us
Products
Solutions
FAQs
Contact Us

Home
1032900-25-6

Products Categories

Antineoplastic
- ACC
- Adenosine A2A
- ALK
- Androgen receptor inhibitor
- Apoptosis stimulant
- ATR
- AXL
- BCl2-BH4
- Bcr-Abl
- BRAF
- BTK
- CDK
- Chk1
- CYP17
- DNA alkylating agent
- EED
- EGFR
- EP4
- ER
- FAK
- FGFR
- FLT3
- Glutaminase
- IDO
- IRA
- KIT
- LXR
- MDM2
- MEK
- MET
- Nrf2
- P90RSK
- P97
- PAKS
- PARP
- PI3K
- Plk-1
- SMYD2
- SRC
- TOPK
- VEGFR
Hypoglycemic drugs
- DPP-4
- SGLT-1
- SGLT-2
Others
- 5HT
- AMPK
- Arginase
- CRF-1
- CXCR2
- FLAP
- FXR
- GABA
- Gi activator
- GR
- JAK
- LABA
- mAChRs
- NF-κB
- NRTI
- PPAR
- RIP1
- S1PR
- SGC
- SYK
- α2δ-1
- αIIbβ3
- β2-adrenoceptor
- σ1

1032900-25-6 - Manufacturers, Factory, Suppliers From China

1032900-25-6, , , , 1032900-25-6,

High Quality 3 – Antineoplastic Api Of Do...
China OEM 9 – Lenvatinib Intermediate - ...
High reputation DS 5565 - EAI-045 – Caer...
China Cheap price Chimecal And Cosmetic Industr...
Bottom price BEC HCl - CP-456773 sodium –...
Cheap PriceList for Breast Carcinoma - MAK683 ...
Excellent quality 1693758-51-8 - CAS: 872509-5...
Special Design for Barbury Wolfberry Fruit P.e....
OEM/ODM China Auricularia Auricula Powder - BL...
Manufacturing Companies for AKP11 - Ozanimod I...
New Arrival China Magnesium Ethylate - BI-8473...
2018 New Style 367514-87-2 Lurasidone - BAR 50...
2018 wholesale price Food Additive Potassium Io...
OEM/ODM Factory 256373-96-3 - BLU-9931 –...
Manufacturing Companies for Vitamin B1 B6 B12 F...
Factory Free sample 1196509-60-0 - CAS: 189626...

Contact Us

3rd Floor, Building 4, 3918 Daye Road, Fengxian District, Shanghai
86-21-64556180
Within China:
sales-cpd@caerulumpharma.com
International:
cpd-service@caerulumpharma.com

Inquiry

For inquiries about our products, please leave your email with us and we will be in touch within 24 hours.Inquiry

Latest News

Top 7 Trends In Pharmaceutical Research I...

Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate in their R&D programmes to stay ahead ...
ARS-1620: A promising new inhibitor for K...

According to a study published in Cell, researchers have developed a specific inhibitor for KRASG12C called ARS-1602 that induced tumor regression in mice. “This study provides in vivo evidence that mutant KRAS can be...
AstraZeneca receives regulatory boost for...

AstraZeneca received a double boost for its oncology portfolio on Tuesday, after US and European regulators accepted regulatory submissions for its drugs, the first step towards winning approval for these medicines. ...

FAQs
Downloadable
Contact Us

QR Code

WhatsApp Online Chat !